RT @cobvl: Das ist leider niederschmetternd: Nach einer Meta-Studie von Cochrane liegt die Wahrscheinlichkeit, dass Schnelltests eine Covid…
RT @tobiaskurth: Bevor wir jetzt in einigen Regionen vieles öffnen für Personen mit einem negativen Schnelltest, sollte man bitte auch die…
@aloa5 Ok Habs gefunden, (ppv und npv) wird im ausführlichen englischem Review berücksichtigt und aufgezeigt https://t.co/6o0P7XSK9y
Hat irgendein Experte denn was anderes erwartet?
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
Ps.. Rapid #SARSCoV2 screening will not end the pandemic, nor allow for mass re-opening of society. Cochrane confirmed: "virtually no evidence for mass screening of asymptomatic individuals using rapid antigen tests in people with no known exposure." ht
RT @cobvl: Das ist leider niederschmetternd: Nach einer Meta-Studie von Cochrane liegt die Wahrscheinlichkeit, dass Schnelltests eine Covid…
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
RT @cobvl: Das ist leider niederschmetternd: Nach einer Meta-Studie von Cochrane liegt die Wahrscheinlichkeit, dass Schnelltests eine Covid…
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
Tja...
RT @MarieCulliton: Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money…
Das ist leider niederschmetternd: Nach einer Meta-Studie von Cochrane liegt die Wahrscheinlichkeit, dass Schnelltests eine Covid-19-Infektion erkennen nur bei 72% (für Menschen mit Symptomen) bzw 58% (für Menschen ohne Symptome) https://t.co/k86aoizmQX
Succinct. Antigen tests are not the panacea. Sensitivity varies. Follow the science not the marketing. Spend the money on sequencing capacity that will have future benefit. @DonnellyStephen @ACSLM1 @CcoHse
RT @rafarotaeche: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection - Dinnes, J - 2021 | Cochran…
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
https://t.co/KoeyKYkatb @Katina_Schubert 👇 Indikationen bitte beachten!
@timspector Many of the LF tests are not accurate enough for ‘test to enable’, certainly not the Innova test which is prob why govt are evaluating others (after wasting several £bn). Good analysis of rapid antigen tests https://t.co/R9WhhaPiW3
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection - Cochrane Library https://t.co/VZu34PCHYa
RT @robeuten: #Covid19 - Herr @RegSprecher, Herr @jensspahn, Herr @Karl_Lauterbach, beim Testen asymptomatischer Menschen mit AG-Schnellte…
@michaelmina_lab @tigeromics @CillianDeGascun @Cochrane_IDG We welcome comments on specific reviews, please see here https://t.co/INZRaZ09nW For this review, you can submit your comment/concerns at https://t.co/oRlUNORCjg so that it may go through the prop
@kh_99 @timspector There’s a recent review of rapid antigen tests here. The Innova test that the govt has spent £bns on doesn’t perform particularly well. https://t.co/R9WhhaPiW3
RT @robeuten: @rosenbusch_ "Man müsste damit rechnen, dass die Tests zwischen 125 und 213 positive Ergebnisse liefern würden und dass zwisc…
RT @CochraneLibrary: UPDATED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Review from @Cochrane_IDG loo…
@mihareality PCR BULSHITT..? STUDIE 24.3.21 https://t.co/ZBMy48tzyM
RT @fascinatorfun: Cochrane Review concludes that even better performing LFT (& Innova is not one of them) perform better on symptomatic pe…
La tecnología falla mucho y sabemos mucho menos de lo que creemos. "In people with confirmed COVID‐19, antigen tests correctly identified COVID‐19 infection in an average of 72% of people with symptoms, compared to 58% of people without symptoms" https://t
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection - Dinnes, J - 2021 | Cochrane Library https://t.co/QYankhpmPN
RT @CochraneLibrary: UPDATED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Review from @Cochrane_IDG loo…
RT @CochraneLibrary: UPDATED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Review from @Cochrane_IDG loo…
RT @cochranecollab: JUST PUBLISHED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/WeJcbVV971 Updated @Cochrane_IDG re…
RT @CochraneLibrary: UPDATED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Review from @Cochrane_IDG loo…
UPDATED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Review from @Cochrane_IDG looks at the evidence from 78 study cohorts, reporting results for 24,087 samples.
@Rengel25504081 @AngelicTrades @StickyStock81 BMJ, this megga review of LFT's. You guys have Mina https://t.co/Jl0hC8WaCK
RT @fascinatorfun: Cochrane Review concludes that even better performing LFT (& Innova is not one of them) perform better on symptomatic pe…
The revered Cochrane Library has reviewed data on 16 LFT's & Prof Deeks analysed. Here's a little look at the #Avacta competition, it's poor but still big challenge to compete against imo https://t.co/Jl0hC8WaCK https://t.co/UPUIgOwyrt
Cochrane Review concludes that even better performing LFT (& Innova is not one of them) perform better on symptomatic people than people with no symptoms & not well in home (self) test conditions I’m worries about what is going on unnoticed.
Die beliebten Antigen Schnelltests erkennen gerade mal knapp mehr als die Hälfte der asymptomatischen Fälle (58%), und drei Viertel der symptomatischen Covid-Infektionen (72%). https://t.co/pMUvG6xMkP
Und das soll die Rettung sein?: 'antigen tests correctly identified COVID‐19 infection in an average of 72% of people with symptoms, compared to 58% of people without symptoms' https://t.co/xxLMpU31pW
What does this mean? Some antigen tests are accurate enough to replace RT‐PCR when used in people with symptoms. This would be most useful when quick decisions are needed about patient care, or if RT‐PCR is not available.
In general, studies that assessed antigen tests used more rigorous methods than those that assessed molecular tests, particularly when selecting participants and performing the tests.
Molecular tests Although overall results for diagnosing and ruling out COVID‐19 were good (95.1% of infections correctly diagnosed and 99% correctly ruled out), 69% of the studies used the tests in laboratories instead of at the point‐of‐care
Antigen tests In people with confirmed COVID‐19, antigen tests correctly identified COVID‐19 infection in an average of 72% of people with symptoms, compared to 58% of people without symptoms.
Rapid point‐of‐care tests could open access to testing for many more people, with and without symptoms, potentially in locations other than healthcare settings. If accurate, faster diagnosis could appropriate action more quickly, with potential to reduce t
Antigen tests identify proteins on the virus; they come in disposable plastic cassettes, similar to pregnancy tests.
Rapid point‐of‐care tests aim to confirm or rule out COVID‐19 infection in people with or without COVID‐19 symptoms. They: ‐ are portable, so they can be used wherever the patient is (at the point of care);
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection https://t.co/sPH15VAQ34 #COVID19antigentesting
@NormalP36820428 @flic83 @Kachelmann Schnelltests nicht überschätzen: https://t.co/9W24OrR1Tl Richtige Identifizierung durch Schnelltests: - Nicht Infizierte 99,5% - Infizierte mit Symptomen 72% - Infizierte ohne Symptome 58% Sehr viel besser als nichts, a
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
RT @robeuten: @DrKissler Beim Testen Asymptomatischer und einer leidlich realistischen Annahme der Prävalenz von 0.5% finden gute kommerzie…
RT @karamballes: 26/26 However we are constantly getting more data that the LFDs used in schools aren't suitable as a replacement for isola…
RT @robeuten: @Jeky @c_lindner Ich habe vor wenigen Tagen geschrieben, daß es reicht, 5% der Gesamtpopulation/Woche zu testen, um eine "Inz…
@Karl_Lauterbach @lisafederle #MarkusLanz Ach du sch... https://t.co/9oGZ2NDM0C Richtige Identifizierung durch Schnelltests: - Nicht Infizierte 99,5% - Infizierte mit Symptomen 72% - Infizierte ohne Symptome 58% Ergo: Eine Welt besser als nichts, aber alle
Bevor wir jetzt in einigen Regionen vieles öffnen für Personen mit einem negativen Schnelltest, sollte man bitte auch die Resultate des neuen #CochraneReviews zu #Schnelltests berücksichtigen. 1/n ⬇️ https://t.co/Mfilsi3fiX
RT @robeuten: @reitschuster Herr Reitschuster, fragen Sie doch einmal zur Abwechslung, warum ASYMPTOMATISCHE Menschen mit Antigen-Schnellte…
Antigen tests were not reliable for detecting #SARSCoV-2 in asymptomatic patients, according to a Cochrane review of nearly 65 studies https://t.co/i6EoYc8uWH #COVID19 #coronavirus #MSSNY
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @robeuten: @rosenbusch_ "Man müsste damit rechnen, dass die Tests zwischen 125 und 213 positive Ergebnisse liefern würden und dass zwisc…
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @robeuten: @reitschuster Herr Reitschuster, fragen Sie doch einmal zur Abwechslung, warum ASYMPTOMATISCHE Menschen mit Antigen-Schnellte…
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
RT @MalariaPapers: Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection https://t.co/IJWNxQxwk2
RT @cochranecollab: JUST PUBLISHED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/WeJcbVV971 Updated @Cochrane_IDG re…
RT @alfonso_casi: Pruebas rápidas moleculares y de antígeno en el lugar de atención para el diagnóstico de la infección por SARS‐CoV‐2: Un…
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection - Dinnes, J - 2021 | Cochrane Library https://t.co/DO6PPcQdUa
RT @CochraneLibrary: JUST PUBLISHED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Updated @Cochrane_IDG r…
RT @florenciatevy: Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #…
RT @cochranecollab: JUST PUBLISHED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/WeJcbVV971 Updated @Cochrane_IDG re…
RT @tlassers: Rapid test performance depends on symptoms in detecting #COVID19: updated @CochraneLibrary review of 64 studies https://t.co/…
Sensitivity of rapid tests for COVID-19 lower when used for screening in asymptomatic people; accuracy varies depending on test brand. Updated review on the @CochraneLibrary: https://t.co/GO9xilq1BK
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
Veredicto sobre los test de antígenos rápido de COVID: detectan sólo el 72% de sintomáticos y el 58% de asintomáticos. #Antigen https://t.co/s2CQn6fCB4
In Indonesia, a negative antigen Covid-19 test result is used as travel requirement. But Cochrane systematic review found it's less accurate to detect infection in people who feel healthy, so some asymptomatic Covid-19 cases may receive a negative result h
@OffRecord2020 @Larry64450205 Even helping evaluate crappy LFT's https://t.co/Wr9TbUwb8c https://t.co/TB3lHUR2O6
RT @CochraneLibrary: JUST PUBLISHED - How accurate are #rapidtests for diagnosing #COVID19? https://t.co/6YKRl32uVx Updated @Cochrane_IDG r…
@michaelmina_lab @SaskiaPopescu @angie_rasmussen @ScienceMagazine This appear to me a thoughtful analysis of LFT's that have been assessed in the UK. Many a stinker. Analysis is based on symptomatic though, picture will be worse with asymptomatic https://
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
RT @Plaza_Bickle: Cochrane ha publicado hoy una revisión de 78 estudios sobre el uso de test de diagnóstico rápido en #COVID19, que incluye…
RT @rwatson1955: "Test accuracy studies cannot adequately assess the ability of antigen tests to differentiate those who are infectious and…
RT @deeksj: Updated @cochranecollab review of Rapid Tests for Covid-19 is here Rapid, point‐of‐care antigen and molecular‐based tests for…
RT @Plaza_Bickle: Cochrane ha publicado hoy una revisión de 78 estudios sobre el uso de test de diagnóstico rápido en #COVID19, que incluye…